EHP Funds Inc’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-125,186
Closed -$7.01K 290
2023
Q3
$7.01K Hold
125,186
﹤0.01% 244
2023
Q2
$17.4K Hold
125,186
﹤0.01% 229
2023
Q1
$10.6K Hold
125,186
﹤0.01% 283
2022
Q4
$6K Sell
125,186
-12,090
-9% -$618 ﹤0.01% 315
2022
Q3
$20K Buy
137,276
+11,071
+9% +$1.23K ﹤0.01% 356
2022
Q2
$18K Buy
+126,205
New +$23.6K ﹤0.01% 386

EHP Funds Inc's BIOSW Position: Q4 2023 in Review

EHP Funds Inc sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 125,186 shares — an estimated $7.01K sold.

EHP Funds Inc first reported a position in BIOSW in Q2 2022 and held it in 6 quarters. The position peaked at $20K in Q3 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

  • EHP Funds Inc reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
  • EHP Funds Inc sold 125,186 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $7.01K.
  • EHP Funds Inc first reported a position in BioPlus Acquisition Corp. Warrants in Q2 2022 and held it in 6 quarters.
  • EHP Funds Inc's BioPlus Acquisition Corp. Warrants position peaked at $20K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on EHP Funds Inc's 13F filing for Q4 2023, filed 14 Feb 2024.